Global Human Vaccine Contract Manufacturing Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The vaccine contract manufacturing sector pertains to the domain where pharmaceutical firms enlist the services of external contract manufacturing entities for the production of vaccines. These contract manufacturing organizations (CMOs) possess the requisite infrastructure, specialized know-how, and dedicated facilities to manufacture vaccines on behalf of the original developers. Contract manufacturers specializing in human use applications are well-equipped to meet the stringent regulatory requirements and quality standards governing vaccine production for human use.
The global Human Vaccine Contract Manufacturing market size is projected to grow from US$ 6570 million in 2024 to US$ 12610 million in 2030; it is expected to grow at a CAGR of 11.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Human Vaccine Contract Manufacturing Industry Forecast” looks at past sales and reviews total world Human Vaccine Contract Manufacturing sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Vaccine Contract Manufacturing sales for 2023 through 2029. With Human Vaccine Contract Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Vaccine Contract Manufacturing industry.
This Insight Report provides a comprehensive analysis of the global Human Vaccine Contract Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Vaccine Contract Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Vaccine Contract Manufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Vaccine Contract Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Vaccine Contract Manufacturing.
Market CAGR for vaccine contract manufacturing is being driven by the rising vaccination rates worldwide. In the ever-evolving landscape of governmental and healthcare endeavors aimed at bolstering immunization coverage against the backdrop of infectious maladies, a pressing imperative emerges—a dire necessity for the expansion of vaccine production capacity. Within this exigent milieu, contract manufacturers emerge as veritable linchpins, wielding their prowess in the domain of vaccine production to furnish a panacea of flexible and scalable manufacturing solutions. Endowed with specialized facilities and unwavering fidelity to regulatory strictures, these entities furnish pharmaceutical behemoths with the instrumental means to orchestrate a seamless augmentation of vaccine production capabilities. The harrowing specter of the COVID-19 pandemic has served to magnify the imperative of fortifying vaccine manufacturing prowess, propelling a surge in investments geared towards the fecundation of vaccine development and production endeavors. As the apogee of vaccination rates is charted across the global expanse, the clamor for the services rendered by vaccine contract manufacturers is poised to ascend to vertiginous heights, heralding an epoch of unprecedented market growth. Enmeshed within the tapestry of the Vaccine Contract Manufacturing Market are the sinews of global health exigencies, wherein the specter of infectious disease outbreaks and the omnipresent shadow of pandemics serve as vanguards propelling the market's ascension. The burgeoning ubiquity of infectious pathogens, intertwined with the looming specter of bioterrorism, accentuates the exigency of vaccines as sentinels of public health. In this crucible of exigency, contract manufacturers emerge as valiant custodians, orchestrating a symphony of vaccine manufacturing prowess to assuage the tremors of global health crises.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Vaccine Contract Manufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
The vaccine contract manufacturing sector pertains to the domain where pharmaceutical firms enlist the services of external contract manufacturing entities for the production of vaccines. These contract manufacturing organizations (CMOs) possess the requisite infrastructure, specialized know-how, and dedicated facilities to manufacture vaccines on behalf of the original developers. Contract manufacturers specializing in human use applications are well-equipped to meet the stringent regulatory requirements and quality standards governing vaccine production for human use.
The global Human Vaccine Contract Manufacturing market size is projected to grow from US$ 6570 million in 2024 to US$ 12610 million in 2030; it is expected to grow at a CAGR of 11.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Human Vaccine Contract Manufacturing Industry Forecast” looks at past sales and reviews total world Human Vaccine Contract Manufacturing sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Vaccine Contract Manufacturing sales for 2023 through 2029. With Human Vaccine Contract Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Vaccine Contract Manufacturing industry.
This Insight Report provides a comprehensive analysis of the global Human Vaccine Contract Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Vaccine Contract Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Vaccine Contract Manufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Vaccine Contract Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Vaccine Contract Manufacturing.
Market CAGR for vaccine contract manufacturing is being driven by the rising vaccination rates worldwide. In the ever-evolving landscape of governmental and healthcare endeavors aimed at bolstering immunization coverage against the backdrop of infectious maladies, a pressing imperative emerges—a dire necessity for the expansion of vaccine production capacity. Within this exigent milieu, contract manufacturers emerge as veritable linchpins, wielding their prowess in the domain of vaccine production to furnish a panacea of flexible and scalable manufacturing solutions. Endowed with specialized facilities and unwavering fidelity to regulatory strictures, these entities furnish pharmaceutical behemoths with the instrumental means to orchestrate a seamless augmentation of vaccine production capabilities. The harrowing specter of the COVID-19 pandemic has served to magnify the imperative of fortifying vaccine manufacturing prowess, propelling a surge in investments geared towards the fecundation of vaccine development and production endeavors. As the apogee of vaccination rates is charted across the global expanse, the clamor for the services rendered by vaccine contract manufacturers is poised to ascend to vertiginous heights, heralding an epoch of unprecedented market growth. Enmeshed within the tapestry of the Vaccine Contract Manufacturing Market are the sinews of global health exigencies, wherein the specter of infectious disease outbreaks and the omnipresent shadow of pandemics serve as vanguards propelling the market's ascension. The burgeoning ubiquity of infectious pathogens, intertwined with the looming specter of bioterrorism, accentuates the exigency of vaccines as sentinels of public health. In this crucible of exigency, contract manufacturers emerge as valiant custodians, orchestrating a symphony of vaccine manufacturing prowess to assuage the tremors of global health crises.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Vaccine Contract Manufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Attenuated
- Inactivated
- Subunit-based
- Toxoid-based
- DNA-based
- Downstream
- Upstream
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Attenuated
- Inactivated
- Subunit-based
- Toxoid-based
- DNA-based
- Downstream
- Upstream
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Fujifilm Diosynth Biotechnologies U.S.A., Inc.
- Ajinomoto Althea, Inc.
- Merck KgaA
- Cytovance Biologics
- Catalent, Inc.
- IDT Biologika GmbH
- Albany Molecular Research, Inc.
- PRA Health Sciences
- ICON plc.
- Pharmaceutical Product Development, LLC
- Cobra Bio
- Paragon Bioservices, Inc.
- Emergent BioSolutions Inc.
- CSL Limited
- BioNTech SE
- Wuxi Biologics
- Samsung Biologics
- Boehringer Ingelheim
- Novavax, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Vaccine Contract Manufacturing Market Size 2019-2030
2.1.2 Human Vaccine Contract Manufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Human Vaccine Contract Manufacturing by Country/Region, 2019, 2023 & 2030
2.2 Human Vaccine Contract Manufacturing Segment by Type
2.2.1 Attenuated
2.2.2 Inactivated
2.2.3 Subunit-based
2.2.4 Toxoid-based
2.2.5 DNA-based
2.3 Human Vaccine Contract Manufacturing Market Size by Type
2.3.1 Human Vaccine Contract Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Human Vaccine Contract Manufacturing Market Size Market Share by Type (2019-2024)
2.4 Human Vaccine Contract Manufacturing Segment by Application
2.4.1 Downstream
2.4.2 Upstream
2.5 Human Vaccine Contract Manufacturing Market Size by Application
2.5.1 Human Vaccine Contract Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Human Vaccine Contract Manufacturing Market Size Market Share by Application (2019-2024)
3 HUMAN VACCINE CONTRACT MANUFACTURING MARKET SIZE BY PLAYER
3.1 Human Vaccine Contract Manufacturing Market Size Market Share by Player
3.1.1 Global Human Vaccine Contract Manufacturing Revenue by Player (2019-2024)
3.1.2 Global Human Vaccine Contract Manufacturing Revenue Market Share by Player (2019-2024)
3.2 Global Human Vaccine Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HUMAN VACCINE CONTRACT MANUFACTURING BY REGION
4.1 Human Vaccine Contract Manufacturing Market Size by Region (2019-2024)
4.2 Global Human Vaccine Contract Manufacturing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Human Vaccine Contract Manufacturing Market Size Growth (2019-2024)
4.4 APAC Human Vaccine Contract Manufacturing Market Size Growth (2019-2024)
4.5 Europe Human Vaccine Contract Manufacturing Market Size Growth (2019-2024)
4.6 Middle East & Africa Human Vaccine Contract Manufacturing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Human Vaccine Contract Manufacturing Market Size by Country (2019-2024)
5.2 Americas Human Vaccine Contract Manufacturing Market Size by Type (2019-2024)
5.3 Americas Human Vaccine Contract Manufacturing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Vaccine Contract Manufacturing Market Size by Region (2019-2024)
6.2 APAC Human Vaccine Contract Manufacturing Market Size by Type (2019-2024)
6.3 APAC Human Vaccine Contract Manufacturing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Human Vaccine Contract Manufacturing Market Size by Country (2019-2024)
7.2 Europe Human Vaccine Contract Manufacturing Market Size by Type (2019-2024)
7.3 Europe Human Vaccine Contract Manufacturing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Vaccine Contract Manufacturing by Region (2019-2024)
8.2 Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Type (2019-2024)
8.3 Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HUMAN VACCINE CONTRACT MANUFACTURING MARKET FORECAST
10.1 Global Human Vaccine Contract Manufacturing Forecast by Region (2025-2030)
10.1.1 Global Human Vaccine Contract Manufacturing Forecast by Region (2025-2030)
10.1.2 Americas Human Vaccine Contract Manufacturing Forecast
10.1.3 APAC Human Vaccine Contract Manufacturing Forecast
10.1.4 Europe Human Vaccine Contract Manufacturing Forecast
10.1.5 Middle East & Africa Human Vaccine Contract Manufacturing Forecast
10.2 Americas Human Vaccine Contract Manufacturing Forecast by Country (2025-2030)
10.2.1 United States Market Human Vaccine Contract Manufacturing Forecast
10.2.2 Canada Market Human Vaccine Contract Manufacturing Forecast
10.2.3 Mexico Market Human Vaccine Contract Manufacturing Forecast
10.2.4 Brazil Market Human Vaccine Contract Manufacturing Forecast
10.3 APAC Human Vaccine Contract Manufacturing Forecast by Region (2025-2030)
10.3.1 China Human Vaccine Contract Manufacturing Market Forecast
10.3.2 Japan Market Human Vaccine Contract Manufacturing Forecast
10.3.3 Korea Market Human Vaccine Contract Manufacturing Forecast
10.3.4 Southeast Asia Market Human Vaccine Contract Manufacturing Forecast
10.3.5 India Market Human Vaccine Contract Manufacturing Forecast
10.3.6 Australia Market Human Vaccine Contract Manufacturing Forecast
10.4 Europe Human Vaccine Contract Manufacturing Forecast by Country (2025-2030)
10.4.1 Germany Market Human Vaccine Contract Manufacturing Forecast
10.4.2 France Market Human Vaccine Contract Manufacturing Forecast
10.4.3 UK Market Human Vaccine Contract Manufacturing Forecast
10.4.4 Italy Market Human Vaccine Contract Manufacturing Forecast
10.4.5 Russia Market Human Vaccine Contract Manufacturing Forecast
10.5 Middle East & Africa Human Vaccine Contract Manufacturing Forecast by Region (2025-2030)
10.5.1 Egypt Market Human Vaccine Contract Manufacturing Forecast
10.5.2 South Africa Market Human Vaccine Contract Manufacturing Forecast
10.5.3 Israel Market Human Vaccine Contract Manufacturing Forecast
10.5.4 Turkey Market Human Vaccine Contract Manufacturing Forecast
10.6 Global Human Vaccine Contract Manufacturing Forecast by Type (2025-2030)
10.7 Global Human Vaccine Contract Manufacturing Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Human Vaccine Contract Manufacturing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Human Vaccine Contract Manufacturing Product Offered
11.1.3 Lonza Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Fujifilm Diosynth Biotechnologies U.S.A., Inc.
11.2.1 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Company Information
11.2.2 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Human Vaccine Contract Manufacturing Product Offered
11.2.3 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Main Business Overview
11.2.5 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Latest Developments
11.3 Ajinomoto Althea, Inc.
11.3.1 Ajinomoto Althea, Inc. Company Information
11.3.2 Ajinomoto Althea, Inc. Human Vaccine Contract Manufacturing Product Offered
11.3.3 Ajinomoto Althea, Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ajinomoto Althea, Inc. Main Business Overview
11.3.5 Ajinomoto Althea, Inc. Latest Developments
11.4 Merck KgaA
11.4.1 Merck KgaA Company Information
11.4.2 Merck KgaA Human Vaccine Contract Manufacturing Product Offered
11.4.3 Merck KgaA Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck KgaA Main Business Overview
11.4.5 Merck KgaA Latest Developments
11.5 Cytovance Biologics
11.5.1 Cytovance Biologics Company Information
11.5.2 Cytovance Biologics Human Vaccine Contract Manufacturing Product Offered
11.5.3 Cytovance Biologics Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cytovance Biologics Main Business Overview
11.5.5 Cytovance Biologics Latest Developments
11.6 Catalent, Inc.
11.6.1 Catalent, Inc. Company Information
11.6.2 Catalent, Inc. Human Vaccine Contract Manufacturing Product Offered
11.6.3 Catalent, Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Catalent, Inc. Main Business Overview
11.6.5 Catalent, Inc. Latest Developments
11.7 IDT Biologika GmbH
11.7.1 IDT Biologika GmbH Company Information
11.7.2 IDT Biologika GmbH Human Vaccine Contract Manufacturing Product Offered
11.7.3 IDT Biologika GmbH Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 IDT Biologika GmbH Main Business Overview
11.7.5 IDT Biologika GmbH Latest Developments
11.8 Albany Molecular Research, Inc.
11.8.1 Albany Molecular Research, Inc. Company Information
11.8.2 Albany Molecular Research, Inc. Human Vaccine Contract Manufacturing Product Offered
11.8.3 Albany Molecular Research, Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Albany Molecular Research, Inc. Main Business Overview
11.8.5 Albany Molecular Research, Inc. Latest Developments
11.9 PRA Health Sciences
11.9.1 PRA Health Sciences Company Information
11.9.2 PRA Health Sciences Human Vaccine Contract Manufacturing Product Offered
11.9.3 PRA Health Sciences Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 PRA Health Sciences Main Business Overview
11.9.5 PRA Health Sciences Latest Developments
11.10 ICON plc.
11.10.1 ICON plc. Company Information
11.10.2 ICON plc. Human Vaccine Contract Manufacturing Product Offered
11.10.3 ICON plc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 ICON plc. Main Business Overview
11.10.5 ICON plc. Latest Developments
11.11 Pharmaceutical Product Development, LLC
11.11.1 Pharmaceutical Product Development, LLC Company Information
11.11.2 Pharmaceutical Product Development, LLC Human Vaccine Contract Manufacturing Product Offered
11.11.3 Pharmaceutical Product Development, LLC Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Pharmaceutical Product Development, LLC Main Business Overview
11.11.5 Pharmaceutical Product Development, LLC Latest Developments
11.12 Cobra Bio
11.12.1 Cobra Bio Company Information
11.12.2 Cobra Bio Human Vaccine Contract Manufacturing Product Offered
11.12.3 Cobra Bio Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Cobra Bio Main Business Overview
11.12.5 Cobra Bio Latest Developments
11.13 Paragon Bioservices, Inc.
11.13.1 Paragon Bioservices, Inc. Company Information
11.13.2 Paragon Bioservices, Inc. Human Vaccine Contract Manufacturing Product Offered
11.13.3 Paragon Bioservices, Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Paragon Bioservices, Inc. Main Business Overview
11.13.5 Paragon Bioservices, Inc. Latest Developments
11.14 Emergent BioSolutions Inc.
11.14.1 Emergent BioSolutions Inc. Company Information
11.14.2 Emergent BioSolutions Inc. Human Vaccine Contract Manufacturing Product Offered
11.14.3 Emergent BioSolutions Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Emergent BioSolutions Inc. Main Business Overview
11.14.5 Emergent BioSolutions Inc. Latest Developments
11.15 CSL Limited
11.15.1 CSL Limited Company Information
11.15.2 CSL Limited Human Vaccine Contract Manufacturing Product Offered
11.15.3 CSL Limited Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 CSL Limited Main Business Overview
11.15.5 CSL Limited Latest Developments
11.16 BioNTech SE
11.16.1 BioNTech SE Company Information
11.16.2 BioNTech SE Human Vaccine Contract Manufacturing Product Offered
11.16.3 BioNTech SE Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 BioNTech SE Main Business Overview
11.16.5 BioNTech SE Latest Developments
11.17 Wuxi Biologics
11.17.1 Wuxi Biologics Company Information
11.17.2 Wuxi Biologics Human Vaccine Contract Manufacturing Product Offered
11.17.3 Wuxi Biologics Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Wuxi Biologics Main Business Overview
11.17.5 Wuxi Biologics Latest Developments
11.18 Samsung Biologics
11.18.1 Samsung Biologics Company Information
11.18.2 Samsung Biologics Human Vaccine Contract Manufacturing Product Offered
11.18.3 Samsung Biologics Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Samsung Biologics Main Business Overview
11.18.5 Samsung Biologics Latest Developments
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Information
11.19.2 Boehringer Ingelheim Human Vaccine Contract Manufacturing Product Offered
11.19.3 Boehringer Ingelheim Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Boehringer Ingelheim Main Business Overview
11.19.5 Boehringer Ingelheim Latest Developments
11.20 Novavax, Inc.
11.20.1 Novavax, Inc. Company Information
11.20.2 Novavax, Inc. Human Vaccine Contract Manufacturing Product Offered
11.20.3 Novavax, Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Novavax, Inc. Main Business Overview
11.20.5 Novavax, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Vaccine Contract Manufacturing Market Size 2019-2030
2.1.2 Human Vaccine Contract Manufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Human Vaccine Contract Manufacturing by Country/Region, 2019, 2023 & 2030
2.2 Human Vaccine Contract Manufacturing Segment by Type
2.2.1 Attenuated
2.2.2 Inactivated
2.2.3 Subunit-based
2.2.4 Toxoid-based
2.2.5 DNA-based
2.3 Human Vaccine Contract Manufacturing Market Size by Type
2.3.1 Human Vaccine Contract Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Human Vaccine Contract Manufacturing Market Size Market Share by Type (2019-2024)
2.4 Human Vaccine Contract Manufacturing Segment by Application
2.4.1 Downstream
2.4.2 Upstream
2.5 Human Vaccine Contract Manufacturing Market Size by Application
2.5.1 Human Vaccine Contract Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Human Vaccine Contract Manufacturing Market Size Market Share by Application (2019-2024)
3 HUMAN VACCINE CONTRACT MANUFACTURING MARKET SIZE BY PLAYER
3.1 Human Vaccine Contract Manufacturing Market Size Market Share by Player
3.1.1 Global Human Vaccine Contract Manufacturing Revenue by Player (2019-2024)
3.1.2 Global Human Vaccine Contract Manufacturing Revenue Market Share by Player (2019-2024)
3.2 Global Human Vaccine Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HUMAN VACCINE CONTRACT MANUFACTURING BY REGION
4.1 Human Vaccine Contract Manufacturing Market Size by Region (2019-2024)
4.2 Global Human Vaccine Contract Manufacturing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Human Vaccine Contract Manufacturing Market Size Growth (2019-2024)
4.4 APAC Human Vaccine Contract Manufacturing Market Size Growth (2019-2024)
4.5 Europe Human Vaccine Contract Manufacturing Market Size Growth (2019-2024)
4.6 Middle East & Africa Human Vaccine Contract Manufacturing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Human Vaccine Contract Manufacturing Market Size by Country (2019-2024)
5.2 Americas Human Vaccine Contract Manufacturing Market Size by Type (2019-2024)
5.3 Americas Human Vaccine Contract Manufacturing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Vaccine Contract Manufacturing Market Size by Region (2019-2024)
6.2 APAC Human Vaccine Contract Manufacturing Market Size by Type (2019-2024)
6.3 APAC Human Vaccine Contract Manufacturing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Human Vaccine Contract Manufacturing Market Size by Country (2019-2024)
7.2 Europe Human Vaccine Contract Manufacturing Market Size by Type (2019-2024)
7.3 Europe Human Vaccine Contract Manufacturing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Vaccine Contract Manufacturing by Region (2019-2024)
8.2 Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Type (2019-2024)
8.3 Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HUMAN VACCINE CONTRACT MANUFACTURING MARKET FORECAST
10.1 Global Human Vaccine Contract Manufacturing Forecast by Region (2025-2030)
10.1.1 Global Human Vaccine Contract Manufacturing Forecast by Region (2025-2030)
10.1.2 Americas Human Vaccine Contract Manufacturing Forecast
10.1.3 APAC Human Vaccine Contract Manufacturing Forecast
10.1.4 Europe Human Vaccine Contract Manufacturing Forecast
10.1.5 Middle East & Africa Human Vaccine Contract Manufacturing Forecast
10.2 Americas Human Vaccine Contract Manufacturing Forecast by Country (2025-2030)
10.2.1 United States Market Human Vaccine Contract Manufacturing Forecast
10.2.2 Canada Market Human Vaccine Contract Manufacturing Forecast
10.2.3 Mexico Market Human Vaccine Contract Manufacturing Forecast
10.2.4 Brazil Market Human Vaccine Contract Manufacturing Forecast
10.3 APAC Human Vaccine Contract Manufacturing Forecast by Region (2025-2030)
10.3.1 China Human Vaccine Contract Manufacturing Market Forecast
10.3.2 Japan Market Human Vaccine Contract Manufacturing Forecast
10.3.3 Korea Market Human Vaccine Contract Manufacturing Forecast
10.3.4 Southeast Asia Market Human Vaccine Contract Manufacturing Forecast
10.3.5 India Market Human Vaccine Contract Manufacturing Forecast
10.3.6 Australia Market Human Vaccine Contract Manufacturing Forecast
10.4 Europe Human Vaccine Contract Manufacturing Forecast by Country (2025-2030)
10.4.1 Germany Market Human Vaccine Contract Manufacturing Forecast
10.4.2 France Market Human Vaccine Contract Manufacturing Forecast
10.4.3 UK Market Human Vaccine Contract Manufacturing Forecast
10.4.4 Italy Market Human Vaccine Contract Manufacturing Forecast
10.4.5 Russia Market Human Vaccine Contract Manufacturing Forecast
10.5 Middle East & Africa Human Vaccine Contract Manufacturing Forecast by Region (2025-2030)
10.5.1 Egypt Market Human Vaccine Contract Manufacturing Forecast
10.5.2 South Africa Market Human Vaccine Contract Manufacturing Forecast
10.5.3 Israel Market Human Vaccine Contract Manufacturing Forecast
10.5.4 Turkey Market Human Vaccine Contract Manufacturing Forecast
10.6 Global Human Vaccine Contract Manufacturing Forecast by Type (2025-2030)
10.7 Global Human Vaccine Contract Manufacturing Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Human Vaccine Contract Manufacturing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Human Vaccine Contract Manufacturing Product Offered
11.1.3 Lonza Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Fujifilm Diosynth Biotechnologies U.S.A., Inc.
11.2.1 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Company Information
11.2.2 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Human Vaccine Contract Manufacturing Product Offered
11.2.3 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Main Business Overview
11.2.5 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Latest Developments
11.3 Ajinomoto Althea, Inc.
11.3.1 Ajinomoto Althea, Inc. Company Information
11.3.2 Ajinomoto Althea, Inc. Human Vaccine Contract Manufacturing Product Offered
11.3.3 Ajinomoto Althea, Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ajinomoto Althea, Inc. Main Business Overview
11.3.5 Ajinomoto Althea, Inc. Latest Developments
11.4 Merck KgaA
11.4.1 Merck KgaA Company Information
11.4.2 Merck KgaA Human Vaccine Contract Manufacturing Product Offered
11.4.3 Merck KgaA Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck KgaA Main Business Overview
11.4.5 Merck KgaA Latest Developments
11.5 Cytovance Biologics
11.5.1 Cytovance Biologics Company Information
11.5.2 Cytovance Biologics Human Vaccine Contract Manufacturing Product Offered
11.5.3 Cytovance Biologics Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cytovance Biologics Main Business Overview
11.5.5 Cytovance Biologics Latest Developments
11.6 Catalent, Inc.
11.6.1 Catalent, Inc. Company Information
11.6.2 Catalent, Inc. Human Vaccine Contract Manufacturing Product Offered
11.6.3 Catalent, Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Catalent, Inc. Main Business Overview
11.6.5 Catalent, Inc. Latest Developments
11.7 IDT Biologika GmbH
11.7.1 IDT Biologika GmbH Company Information
11.7.2 IDT Biologika GmbH Human Vaccine Contract Manufacturing Product Offered
11.7.3 IDT Biologika GmbH Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 IDT Biologika GmbH Main Business Overview
11.7.5 IDT Biologika GmbH Latest Developments
11.8 Albany Molecular Research, Inc.
11.8.1 Albany Molecular Research, Inc. Company Information
11.8.2 Albany Molecular Research, Inc. Human Vaccine Contract Manufacturing Product Offered
11.8.3 Albany Molecular Research, Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Albany Molecular Research, Inc. Main Business Overview
11.8.5 Albany Molecular Research, Inc. Latest Developments
11.9 PRA Health Sciences
11.9.1 PRA Health Sciences Company Information
11.9.2 PRA Health Sciences Human Vaccine Contract Manufacturing Product Offered
11.9.3 PRA Health Sciences Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 PRA Health Sciences Main Business Overview
11.9.5 PRA Health Sciences Latest Developments
11.10 ICON plc.
11.10.1 ICON plc. Company Information
11.10.2 ICON plc. Human Vaccine Contract Manufacturing Product Offered
11.10.3 ICON plc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 ICON plc. Main Business Overview
11.10.5 ICON plc. Latest Developments
11.11 Pharmaceutical Product Development, LLC
11.11.1 Pharmaceutical Product Development, LLC Company Information
11.11.2 Pharmaceutical Product Development, LLC Human Vaccine Contract Manufacturing Product Offered
11.11.3 Pharmaceutical Product Development, LLC Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Pharmaceutical Product Development, LLC Main Business Overview
11.11.5 Pharmaceutical Product Development, LLC Latest Developments
11.12 Cobra Bio
11.12.1 Cobra Bio Company Information
11.12.2 Cobra Bio Human Vaccine Contract Manufacturing Product Offered
11.12.3 Cobra Bio Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Cobra Bio Main Business Overview
11.12.5 Cobra Bio Latest Developments
11.13 Paragon Bioservices, Inc.
11.13.1 Paragon Bioservices, Inc. Company Information
11.13.2 Paragon Bioservices, Inc. Human Vaccine Contract Manufacturing Product Offered
11.13.3 Paragon Bioservices, Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Paragon Bioservices, Inc. Main Business Overview
11.13.5 Paragon Bioservices, Inc. Latest Developments
11.14 Emergent BioSolutions Inc.
11.14.1 Emergent BioSolutions Inc. Company Information
11.14.2 Emergent BioSolutions Inc. Human Vaccine Contract Manufacturing Product Offered
11.14.3 Emergent BioSolutions Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Emergent BioSolutions Inc. Main Business Overview
11.14.5 Emergent BioSolutions Inc. Latest Developments
11.15 CSL Limited
11.15.1 CSL Limited Company Information
11.15.2 CSL Limited Human Vaccine Contract Manufacturing Product Offered
11.15.3 CSL Limited Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 CSL Limited Main Business Overview
11.15.5 CSL Limited Latest Developments
11.16 BioNTech SE
11.16.1 BioNTech SE Company Information
11.16.2 BioNTech SE Human Vaccine Contract Manufacturing Product Offered
11.16.3 BioNTech SE Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 BioNTech SE Main Business Overview
11.16.5 BioNTech SE Latest Developments
11.17 Wuxi Biologics
11.17.1 Wuxi Biologics Company Information
11.17.2 Wuxi Biologics Human Vaccine Contract Manufacturing Product Offered
11.17.3 Wuxi Biologics Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Wuxi Biologics Main Business Overview
11.17.5 Wuxi Biologics Latest Developments
11.18 Samsung Biologics
11.18.1 Samsung Biologics Company Information
11.18.2 Samsung Biologics Human Vaccine Contract Manufacturing Product Offered
11.18.3 Samsung Biologics Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Samsung Biologics Main Business Overview
11.18.5 Samsung Biologics Latest Developments
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Information
11.19.2 Boehringer Ingelheim Human Vaccine Contract Manufacturing Product Offered
11.19.3 Boehringer Ingelheim Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Boehringer Ingelheim Main Business Overview
11.19.5 Boehringer Ingelheim Latest Developments
11.20 Novavax, Inc.
11.20.1 Novavax, Inc. Company Information
11.20.2 Novavax, Inc. Human Vaccine Contract Manufacturing Product Offered
11.20.3 Novavax, Inc. Human Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Novavax, Inc. Main Business Overview
11.20.5 Novavax, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Vaccine Contract Manufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Human Vaccine Contract Manufacturing Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Attenuated
Table 4. Major Players of Inactivated
Table 5. Major Players of Subunit-based
Table 6. Major Players of Toxoid-based
Table 7. Major Players of DNA-based
Table 8. Human Vaccine Contract Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Human Vaccine Contract Manufacturing Market Size by Type (2019-2024) & ($ millions)
Table 10. Global Human Vaccine Contract Manufacturing Market Size Market Share by Type (2019-2024)
Table 11. Human Vaccine Contract Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 12. Global Human Vaccine Contract Manufacturing Market Size by Application (2019-2024) & ($ millions)
Table 13. Global Human Vaccine Contract Manufacturing Market Size Market Share by Application (2019-2024)
Table 14. Global Human Vaccine Contract Manufacturing Revenue by Player (2019-2024) & ($ millions)
Table 15. Global Human Vaccine Contract Manufacturing Revenue Market Share by Player (2019-2024)
Table 16. Human Vaccine Contract Manufacturing Key Players Head office and Products Offered
Table 17. Human Vaccine Contract Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Human Vaccine Contract Manufacturing Market Size by Region (2019-2024) & ($ millions)
Table 21. Global Human Vaccine Contract Manufacturing Market Size Market Share by Region (2019-2024)
Table 22. Global Human Vaccine Contract Manufacturing Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Human Vaccine Contract Manufacturing Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Human Vaccine Contract Manufacturing Market Size by Country (2019-2024) & ($ millions)
Table 25. Americas Human Vaccine Contract Manufacturing Market Size Market Share by Country (2019-2024)
Table 26. Americas Human Vaccine Contract Manufacturing Market Size by Type (2019-2024) & ($ millions)
Table 27. Americas Human Vaccine Contract Manufacturing Market Size Market Share by Type (2019-2024)
Table 28. Americas Human Vaccine Contract Manufacturing Market Size by Application (2019-2024) & ($ millions)
Table 29. Americas Human Vaccine Contract Manufacturing Market Size Market Share by Application (2019-2024)
Table 30. APAC Human Vaccine Contract Manufacturing Market Size by Region (2019-2024) & ($ millions)
Table 31. APAC Human Vaccine Contract Manufacturing Market Size Market Share by Region (2019-2024)
Table 32. APAC Human Vaccine Contract Manufacturing Market Size by Type (2019-2024) & ($ millions)
Table 33. APAC Human Vaccine Contract Manufacturing Market Size by Application (2019-2024) & ($ millions)
Table 34. Europe Human Vaccine Contract Manufacturing Market Size by Country (2019-2024) & ($ millions)
Table 35. Europe Human Vaccine Contract Manufacturing Market Size Market Share by Country (2019-2024)
Table 36. Europe Human Vaccine Contract Manufacturing Market Size by Type (2019-2024) & ($ millions)
Table 37. Europe Human Vaccine Contract Manufacturing Market Size by Application (2019-2024) & ($ millions)
Table 38. Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Region (2019-2024) & ($ millions)
Table 39. Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Type (2019-2024) & ($ millions)
Table 40. Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Application (2019-2024) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Human Vaccine Contract Manufacturing
Table 42. Key Market Challenges & Risks of Human Vaccine Contract Manufacturing
Table 43. Key Industry Trends of Human Vaccine Contract Manufacturing
Table 44. Global Human Vaccine Contract Manufacturing Market Size Forecast by Region (2025-2030) & ($ millions)
Table 45. Global Human Vaccine Contract Manufacturing Market Size Market Share Forecast by Region (2025-2030)
Table 46. Global Human Vaccine Contract Manufacturing Market Size Forecast by Type (2025-2030) & ($ millions)
Table 47. Global Human Vaccine Contract Manufacturing Market Size Forecast by Application (2025-2030) & ($ millions)
Table 48. Lonza Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 49. Lonza Human Vaccine Contract Manufacturing Product Offered
Table 50. Lonza Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 51. Lonza Main Business
Table 52. Lonza Latest Developments
Table 53. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 54. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Human Vaccine Contract Manufacturing Product Offered
Table 55. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Main Business
Table 57. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Latest Developments
Table 58. Ajinomoto Althea, Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 59. Ajinomoto Althea, Inc. Human Vaccine Contract Manufacturing Product Offered
Table 60. Ajinomoto Althea, Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Ajinomoto Althea, Inc. Main Business
Table 62. Ajinomoto Althea, Inc. Latest Developments
Table 63. Merck KgaA Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 64. Merck KgaA Human Vaccine Contract Manufacturing Product Offered
Table 65. Merck KgaA Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Merck KgaA Main Business
Table 67. Merck KgaA Latest Developments
Table 68. Cytovance Biologics Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 69. Cytovance Biologics Human Vaccine Contract Manufacturing Product Offered
Table 70. Cytovance Biologics Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Cytovance Biologics Main Business
Table 72. Cytovance Biologics Latest Developments
Table 73. Catalent, Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 74. Catalent, Inc. Human Vaccine Contract Manufacturing Product Offered
Table 75. Catalent, Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Catalent, Inc. Main Business
Table 77. Catalent, Inc. Latest Developments
Table 78. IDT Biologika GmbH Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 79. IDT Biologika GmbH Human Vaccine Contract Manufacturing Product Offered
Table 80. IDT Biologika GmbH Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. IDT Biologika GmbH Main Business
Table 82. IDT Biologika GmbH Latest Developments
Table 83. Albany Molecular Research, Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 84. Albany Molecular Research, Inc. Human Vaccine Contract Manufacturing Product Offered
Table 85. Albany Molecular Research, Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Albany Molecular Research, Inc. Main Business
Table 87. Albany Molecular Research, Inc. Latest Developments
Table 88. PRA Health Sciences Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 89. PRA Health Sciences Human Vaccine Contract Manufacturing Product Offered
Table 90. PRA Health Sciences Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. PRA Health Sciences Main Business
Table 92. PRA Health Sciences Latest Developments
Table 93. ICON plc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 94. ICON plc. Human Vaccine Contract Manufacturing Product Offered
Table 95. ICON plc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. ICON plc. Main Business
Table 97. ICON plc. Latest Developments
Table 98. Pharmaceutical Product Development, LLC Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 99. Pharmaceutical Product Development, LLC Human Vaccine Contract Manufacturing Product Offered
Table 100. Pharmaceutical Product Development, LLC Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Pharmaceutical Product Development, LLC Main Business
Table 102. Pharmaceutical Product Development, LLC Latest Developments
Table 103. Cobra Bio Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 104. Cobra Bio Human Vaccine Contract Manufacturing Product Offered
Table 105. Cobra Bio Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Cobra Bio Main Business
Table 107. Cobra Bio Latest Developments
Table 108. Paragon Bioservices, Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 109. Paragon Bioservices, Inc. Human Vaccine Contract Manufacturing Product Offered
Table 110. Paragon Bioservices, Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Paragon Bioservices, Inc. Main Business
Table 112. Paragon Bioservices, Inc. Latest Developments
Table 113. Emergent BioSolutions Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 114. Emergent BioSolutions Inc. Human Vaccine Contract Manufacturing Product Offered
Table 115. Emergent BioSolutions Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Emergent BioSolutions Inc. Main Business
Table 117. Emergent BioSolutions Inc. Latest Developments
Table 118. CSL Limited Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 119. CSL Limited Human Vaccine Contract Manufacturing Product Offered
Table 120. CSL Limited Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. CSL Limited Main Business
Table 122. CSL Limited Latest Developments
Table 123. BioNTech SE Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 124. BioNTech SE Human Vaccine Contract Manufacturing Product Offered
Table 125. BioNTech SE Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. BioNTech SE Main Business
Table 127. BioNTech SE Latest Developments
Table 128. Wuxi Biologics Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 129. Wuxi Biologics Human Vaccine Contract Manufacturing Product Offered
Table 130. Wuxi Biologics Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Wuxi Biologics Main Business
Table 132. Wuxi Biologics Latest Developments
Table 133. Samsung Biologics Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 134. Samsung Biologics Human Vaccine Contract Manufacturing Product Offered
Table 135. Samsung Biologics Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Samsung Biologics Main Business
Table 137. Samsung Biologics Latest Developments
Table 138. Boehringer Ingelheim Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 139. Boehringer Ingelheim Human Vaccine Contract Manufacturing Product Offered
Table 140. Boehringer Ingelheim Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Boehringer Ingelheim Main Business
Table 142. Boehringer Ingelheim Latest Developments
Table 143. Novavax, Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 144. Novavax, Inc. Human Vaccine Contract Manufacturing Product Offered
Table 145. Novavax, Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. Novavax, Inc. Main Business
Table 147. Novavax, Inc. Latest Developments
Table 1. Human Vaccine Contract Manufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Human Vaccine Contract Manufacturing Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Attenuated
Table 4. Major Players of Inactivated
Table 5. Major Players of Subunit-based
Table 6. Major Players of Toxoid-based
Table 7. Major Players of DNA-based
Table 8. Human Vaccine Contract Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Human Vaccine Contract Manufacturing Market Size by Type (2019-2024) & ($ millions)
Table 10. Global Human Vaccine Contract Manufacturing Market Size Market Share by Type (2019-2024)
Table 11. Human Vaccine Contract Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 12. Global Human Vaccine Contract Manufacturing Market Size by Application (2019-2024) & ($ millions)
Table 13. Global Human Vaccine Contract Manufacturing Market Size Market Share by Application (2019-2024)
Table 14. Global Human Vaccine Contract Manufacturing Revenue by Player (2019-2024) & ($ millions)
Table 15. Global Human Vaccine Contract Manufacturing Revenue Market Share by Player (2019-2024)
Table 16. Human Vaccine Contract Manufacturing Key Players Head office and Products Offered
Table 17. Human Vaccine Contract Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Human Vaccine Contract Manufacturing Market Size by Region (2019-2024) & ($ millions)
Table 21. Global Human Vaccine Contract Manufacturing Market Size Market Share by Region (2019-2024)
Table 22. Global Human Vaccine Contract Manufacturing Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Human Vaccine Contract Manufacturing Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Human Vaccine Contract Manufacturing Market Size by Country (2019-2024) & ($ millions)
Table 25. Americas Human Vaccine Contract Manufacturing Market Size Market Share by Country (2019-2024)
Table 26. Americas Human Vaccine Contract Manufacturing Market Size by Type (2019-2024) & ($ millions)
Table 27. Americas Human Vaccine Contract Manufacturing Market Size Market Share by Type (2019-2024)
Table 28. Americas Human Vaccine Contract Manufacturing Market Size by Application (2019-2024) & ($ millions)
Table 29. Americas Human Vaccine Contract Manufacturing Market Size Market Share by Application (2019-2024)
Table 30. APAC Human Vaccine Contract Manufacturing Market Size by Region (2019-2024) & ($ millions)
Table 31. APAC Human Vaccine Contract Manufacturing Market Size Market Share by Region (2019-2024)
Table 32. APAC Human Vaccine Contract Manufacturing Market Size by Type (2019-2024) & ($ millions)
Table 33. APAC Human Vaccine Contract Manufacturing Market Size by Application (2019-2024) & ($ millions)
Table 34. Europe Human Vaccine Contract Manufacturing Market Size by Country (2019-2024) & ($ millions)
Table 35. Europe Human Vaccine Contract Manufacturing Market Size Market Share by Country (2019-2024)
Table 36. Europe Human Vaccine Contract Manufacturing Market Size by Type (2019-2024) & ($ millions)
Table 37. Europe Human Vaccine Contract Manufacturing Market Size by Application (2019-2024) & ($ millions)
Table 38. Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Region (2019-2024) & ($ millions)
Table 39. Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Type (2019-2024) & ($ millions)
Table 40. Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Application (2019-2024) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Human Vaccine Contract Manufacturing
Table 42. Key Market Challenges & Risks of Human Vaccine Contract Manufacturing
Table 43. Key Industry Trends of Human Vaccine Contract Manufacturing
Table 44. Global Human Vaccine Contract Manufacturing Market Size Forecast by Region (2025-2030) & ($ millions)
Table 45. Global Human Vaccine Contract Manufacturing Market Size Market Share Forecast by Region (2025-2030)
Table 46. Global Human Vaccine Contract Manufacturing Market Size Forecast by Type (2025-2030) & ($ millions)
Table 47. Global Human Vaccine Contract Manufacturing Market Size Forecast by Application (2025-2030) & ($ millions)
Table 48. Lonza Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 49. Lonza Human Vaccine Contract Manufacturing Product Offered
Table 50. Lonza Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 51. Lonza Main Business
Table 52. Lonza Latest Developments
Table 53. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 54. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Human Vaccine Contract Manufacturing Product Offered
Table 55. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Main Business
Table 57. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Latest Developments
Table 58. Ajinomoto Althea, Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 59. Ajinomoto Althea, Inc. Human Vaccine Contract Manufacturing Product Offered
Table 60. Ajinomoto Althea, Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Ajinomoto Althea, Inc. Main Business
Table 62. Ajinomoto Althea, Inc. Latest Developments
Table 63. Merck KgaA Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 64. Merck KgaA Human Vaccine Contract Manufacturing Product Offered
Table 65. Merck KgaA Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Merck KgaA Main Business
Table 67. Merck KgaA Latest Developments
Table 68. Cytovance Biologics Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 69. Cytovance Biologics Human Vaccine Contract Manufacturing Product Offered
Table 70. Cytovance Biologics Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Cytovance Biologics Main Business
Table 72. Cytovance Biologics Latest Developments
Table 73. Catalent, Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 74. Catalent, Inc. Human Vaccine Contract Manufacturing Product Offered
Table 75. Catalent, Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Catalent, Inc. Main Business
Table 77. Catalent, Inc. Latest Developments
Table 78. IDT Biologika GmbH Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 79. IDT Biologika GmbH Human Vaccine Contract Manufacturing Product Offered
Table 80. IDT Biologika GmbH Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. IDT Biologika GmbH Main Business
Table 82. IDT Biologika GmbH Latest Developments
Table 83. Albany Molecular Research, Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 84. Albany Molecular Research, Inc. Human Vaccine Contract Manufacturing Product Offered
Table 85. Albany Molecular Research, Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Albany Molecular Research, Inc. Main Business
Table 87. Albany Molecular Research, Inc. Latest Developments
Table 88. PRA Health Sciences Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 89. PRA Health Sciences Human Vaccine Contract Manufacturing Product Offered
Table 90. PRA Health Sciences Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. PRA Health Sciences Main Business
Table 92. PRA Health Sciences Latest Developments
Table 93. ICON plc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 94. ICON plc. Human Vaccine Contract Manufacturing Product Offered
Table 95. ICON plc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. ICON plc. Main Business
Table 97. ICON plc. Latest Developments
Table 98. Pharmaceutical Product Development, LLC Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 99. Pharmaceutical Product Development, LLC Human Vaccine Contract Manufacturing Product Offered
Table 100. Pharmaceutical Product Development, LLC Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Pharmaceutical Product Development, LLC Main Business
Table 102. Pharmaceutical Product Development, LLC Latest Developments
Table 103. Cobra Bio Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 104. Cobra Bio Human Vaccine Contract Manufacturing Product Offered
Table 105. Cobra Bio Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Cobra Bio Main Business
Table 107. Cobra Bio Latest Developments
Table 108. Paragon Bioservices, Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 109. Paragon Bioservices, Inc. Human Vaccine Contract Manufacturing Product Offered
Table 110. Paragon Bioservices, Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Paragon Bioservices, Inc. Main Business
Table 112. Paragon Bioservices, Inc. Latest Developments
Table 113. Emergent BioSolutions Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 114. Emergent BioSolutions Inc. Human Vaccine Contract Manufacturing Product Offered
Table 115. Emergent BioSolutions Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Emergent BioSolutions Inc. Main Business
Table 117. Emergent BioSolutions Inc. Latest Developments
Table 118. CSL Limited Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 119. CSL Limited Human Vaccine Contract Manufacturing Product Offered
Table 120. CSL Limited Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. CSL Limited Main Business
Table 122. CSL Limited Latest Developments
Table 123. BioNTech SE Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 124. BioNTech SE Human Vaccine Contract Manufacturing Product Offered
Table 125. BioNTech SE Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. BioNTech SE Main Business
Table 127. BioNTech SE Latest Developments
Table 128. Wuxi Biologics Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 129. Wuxi Biologics Human Vaccine Contract Manufacturing Product Offered
Table 130. Wuxi Biologics Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Wuxi Biologics Main Business
Table 132. Wuxi Biologics Latest Developments
Table 133. Samsung Biologics Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 134. Samsung Biologics Human Vaccine Contract Manufacturing Product Offered
Table 135. Samsung Biologics Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Samsung Biologics Main Business
Table 137. Samsung Biologics Latest Developments
Table 138. Boehringer Ingelheim Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 139. Boehringer Ingelheim Human Vaccine Contract Manufacturing Product Offered
Table 140. Boehringer Ingelheim Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Boehringer Ingelheim Main Business
Table 142. Boehringer Ingelheim Latest Developments
Table 143. Novavax, Inc. Details, Company Type, Human Vaccine Contract Manufacturing Area Served and Its Competitors
Table 144. Novavax, Inc. Human Vaccine Contract Manufacturing Product Offered
Table 145. Novavax, Inc. Human Vaccine Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. Novavax, Inc. Main Business
Table 147. Novavax, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Human Vaccine Contract Manufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Vaccine Contract Manufacturing Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Human Vaccine Contract Manufacturing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Human Vaccine Contract Manufacturing Sales Market Share by Country/Region (2023)
Figure 8. Human Vaccine Contract Manufacturing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Human Vaccine Contract Manufacturing Market Size Market Share by Type in 2023
Figure 10. Human Vaccine Contract Manufacturing in Downstream
Figure 11. Global Human Vaccine Contract Manufacturing Market: Downstream (2019-2024) & ($ millions)
Figure 12. Human Vaccine Contract Manufacturing in Upstream
Figure 13. Global Human Vaccine Contract Manufacturing Market: Upstream (2019-2024) & ($ millions)
Figure 14. Global Human Vaccine Contract Manufacturing Market Size Market Share by Application in 2023
Figure 15. Global Human Vaccine Contract Manufacturing Revenue Market Share by Player in 2023
Figure 16. Global Human Vaccine Contract Manufacturing Market Size Market Share by Region (2019-2024)
Figure 17. Americas Human Vaccine Contract Manufacturing Market Size 2019-2024 ($ millions)
Figure 18. APAC Human Vaccine Contract Manufacturing Market Size 2019-2024 ($ millions)
Figure 19. Europe Human Vaccine Contract Manufacturing Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Human Vaccine Contract Manufacturing Market Size 2019-2024 ($ millions)
Figure 21. Americas Human Vaccine Contract Manufacturing Value Market Share by Country in 2023
Figure 22. United States Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Human Vaccine Contract Manufacturing Market Size Market Share by Region in 2023
Figure 27. APAC Human Vaccine Contract Manufacturing Market Size Market Share by Type (2019-2024)
Figure 28. APAC Human Vaccine Contract Manufacturing Market Size Market Share by Application (2019-2024)
Figure 29. China Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 33. India Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Human Vaccine Contract Manufacturing Market Size Market Share by Country in 2023
Figure 36. Europe Human Vaccine Contract Manufacturing Market Size Market Share by Type (2019-2024)
Figure 37. Europe Human Vaccine Contract Manufacturing Market Size Market Share by Application (2019-2024)
Figure 38. Germany Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 39. France Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Human Vaccine Contract Manufacturing Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Human Vaccine Contract Manufacturing Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Human Vaccine Contract Manufacturing Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 52. APAC Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 53. Europe Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 55. United States Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 56. Canada Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 57. Mexico Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 58. Brazil Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 59. China Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 60. Japan Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 61. Korea Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 63. India Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 64. Australia Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 65. Germany Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 66. France Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 67. UK Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 68. Italy Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 69. Russia Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 70. Egypt Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 71. South Africa Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 72. Israel Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 73. Turkey Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 75. Global Human Vaccine Contract Manufacturing Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Human Vaccine Contract Manufacturing Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Human Vaccine Contract Manufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Vaccine Contract Manufacturing Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Human Vaccine Contract Manufacturing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Human Vaccine Contract Manufacturing Sales Market Share by Country/Region (2023)
Figure 8. Human Vaccine Contract Manufacturing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Human Vaccine Contract Manufacturing Market Size Market Share by Type in 2023
Figure 10. Human Vaccine Contract Manufacturing in Downstream
Figure 11. Global Human Vaccine Contract Manufacturing Market: Downstream (2019-2024) & ($ millions)
Figure 12. Human Vaccine Contract Manufacturing in Upstream
Figure 13. Global Human Vaccine Contract Manufacturing Market: Upstream (2019-2024) & ($ millions)
Figure 14. Global Human Vaccine Contract Manufacturing Market Size Market Share by Application in 2023
Figure 15. Global Human Vaccine Contract Manufacturing Revenue Market Share by Player in 2023
Figure 16. Global Human Vaccine Contract Manufacturing Market Size Market Share by Region (2019-2024)
Figure 17. Americas Human Vaccine Contract Manufacturing Market Size 2019-2024 ($ millions)
Figure 18. APAC Human Vaccine Contract Manufacturing Market Size 2019-2024 ($ millions)
Figure 19. Europe Human Vaccine Contract Manufacturing Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Human Vaccine Contract Manufacturing Market Size 2019-2024 ($ millions)
Figure 21. Americas Human Vaccine Contract Manufacturing Value Market Share by Country in 2023
Figure 22. United States Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Human Vaccine Contract Manufacturing Market Size Market Share by Region in 2023
Figure 27. APAC Human Vaccine Contract Manufacturing Market Size Market Share by Type (2019-2024)
Figure 28. APAC Human Vaccine Contract Manufacturing Market Size Market Share by Application (2019-2024)
Figure 29. China Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 33. India Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Human Vaccine Contract Manufacturing Market Size Market Share by Country in 2023
Figure 36. Europe Human Vaccine Contract Manufacturing Market Size Market Share by Type (2019-2024)
Figure 37. Europe Human Vaccine Contract Manufacturing Market Size Market Share by Application (2019-2024)
Figure 38. Germany Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 39. France Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Human Vaccine Contract Manufacturing Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Human Vaccine Contract Manufacturing Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Human Vaccine Contract Manufacturing Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Human Vaccine Contract Manufacturing Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 52. APAC Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 53. Europe Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 55. United States Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 56. Canada Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 57. Mexico Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 58. Brazil Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 59. China Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 60. Japan Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 61. Korea Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 63. India Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 64. Australia Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 65. Germany Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 66. France Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 67. UK Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 68. Italy Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 69. Russia Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 70. Egypt Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 71. South Africa Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 72. Israel Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 73. Turkey Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Human Vaccine Contract Manufacturing Market Size 2025-2030 ($ millions)
Figure 75. Global Human Vaccine Contract Manufacturing Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Human Vaccine Contract Manufacturing Market Size Market Share Forecast by Application (2025-2030)
